Free Trial

Grace Therapeutics (GRCE) SEC Filings & 10K Form

Grace Therapeutics logo
$2.71 +0.10 (+3.83%)
As of 04:00 PM Eastern

Recent Grace Therapeutics SEC Filings

DateFilerForm TypeView
04/16/2025
7:58 PM
D'Andrea Carrie (Reporting)
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:58 PM
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Kohli Prashant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:58 PM
DelAversano Robert J (Reporting)
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:58 PM
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Macdonald R. Loch (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:58 PM
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Kumar Amresh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
7:00 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
11:15 PM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form EFFECT
03/10/2025
6:58 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/03/2025
7:00 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
2:05 PM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
02/18/2025
7:25 PM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-Q/A
02/13/2025
7:00 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
6:30 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/10/2025
7:11 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
5:13 AM
Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SCHEDULE 13G/A
11/14/2024
10:58 AM
BANK OF AMERICA CORP /DE/ (Filed by)
Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
Form SC 13G/A
11/13/2024
7:00 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
6:30 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2024
7:22 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
7:13 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
11:15 PM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form EFFECT
10/15/2024
11:15 PM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form EFFECT
10/08/2024
6:22 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/08/2024
6:13 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form POS AM
10/08/2024
6:15 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form POS AM
10/08/2024
6:16 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-8 POS
10/08/2024
6:16 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-8 POS
10/08/2024
6:16 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-8 POS
09/30/2024
3:31 PM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
7:00 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
7:00 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
6:30 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:14 PM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 424B3
08/04/2024
11:15 PM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form EFFECT
07/31/2024
6:22 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-4/A
07/11/2024
10:16 AM
Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
Form 3/A
07/10/2024
8:10 PM
Acasti Pharma Inc. (Subject)
Grace Therapeutics (Subject)
ADAR1 Capital Management, LLC (Filed by)
Form SC 13G
07/09/2024
7:29 PM
Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
4:01 PM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
06/21/2024
7:00 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
6:30 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
Musk's warning signal: Prepare before the cascade begins (Ad)

When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.

Watch the Musk market warning before the dominoes fall
05/08/2024
6:18 PM
Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
Kohli Prashant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:18 PM
Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
DelAversano Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:19 PM
Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
Macdonald R. Loch (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:19 PM
Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
Kumar Amresh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:19 PM
Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
D'Andrea Carrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GRCE) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners